| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $180.8M | — | +9.6% |
| Cost of Revenue | $33.2M | — | +7.1% |
| R&D Expense | $45.4M | — | +1.5% |
| SG&A Expense | $25.7M | — | -3.1% |
| Operating Income | $15.6M | — | +131.2% |
| Interest Expense | $413K | — | -1.7% |
| Pre-tax Income | $14.2M | — | +49.4% |
| Income Tax | $7.8M | — | +9.2% |
| Net Income | $6.4M | — | +171.5% |
| EPS (Basic) | $0.04 | — | +300.0% |
| EPS (Diluted) | $0.04 | — | +300.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $173.8M | -32.9% | +11.2% |
| Accounts Receivable | $222.6M | +0.6% | +4.3% |
| Current Assets | $451.4M | -13.1% | +7.0% |
| Total Assets | $1.27B | -5.9% | +2.0% |
| Current Liabilities | $94.6M | -22.2% | -16.6% |
| Total Liabilities | $193.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $4.2M | — | -88.9% |
| Capital Expenditures | $10.5M | — | +67.7% |
| Investing Cash Flow | -$10.5M | — | +88.3% |
| Financing Cash Flow | -$78.1M | — | +8.9% |
| Free Cash Flow | -$6.4M | — | -120.3% |
| -10.8% |
| Stockholders' Equity | $1.08B | -4.4% | +4.7% |